Hugues de Lavallade
- Hematology top 0.2%
- Genetics top 0.2%
- Rheumatology top 0.5%
- Oncology top 5%
- Immunology top 5%
- Co-authors
- Jane F. ApperleyDragana MilojkovićJamshid S. KhorashadDavid MarínAlistair ReidJohn M. GoldmanMarco BuaRichard Szydlo
- Topics
- Chronic Myeloid Leukemia Treatments (49 papers)Chronic Lymphocytic Leukemia Research (38 papers)Eosinophilic Disorders and Syndromes (24 papers)
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- United KingdomFranceUnited States
In The Last Decade
Hugues de Lavallade
79 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Hematology 2.6k
- Genetics 1.8k
- Rheumatology 1.0k
- Oncology 612
- Immunology 494
Countries citing papers authored by Hugues de Lavallade
This map shows the geographic impact of Hugues de Lavallade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugues de Lavallade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugues de Lavallade more than expected).
Fields of papers citing papers by Hugues de Lavallade
This network shows the impact of papers produced by Hugues de Lavallade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugues de Lavallade. The network helps show where Hugues de Lavallade may publish in the future.
Co-authorship network of co-authors of Hugues de Lavallade
This figure shows the co-authorship network connecting the top 25 collaborators of Hugues de Lavallade. A scholar is included among the top collaborators of Hugues de Lavallade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugues de Lavallade. Hugues de Lavallade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 7 | |
| 4 | 8 | |
| 5 | 31 | |
| 6 | 5 | |
| 7 | 5 | |
| 8 | 5 | |
| 9 | 98 | |
| 10 | 11 | |
| 11 | 158 | |
| 12 | 15 | |
| 13 | Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinibbreakdown → | 674 |
| 14 | 15 | |
| 15 | 23 | |
| 16 | 416 | |
| 17 | 144 | |
| 18 | 49 | |
| 19 | 79 | |
| 20 | 30 |
About Hugues de Lavallade
Hugues de Lavallade is a scholar working on Hematology, Genetics and Rheumatology, having authored 82 papers that have together received 3.3k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (49 papers), Chronic Lymphocytic Leukemia Research (38 papers) and Eosinophilic Disorders and Syndromes (24 papers). The work is most often cited by research in Hematology (2.6k citations), Genetics (1.8k citations) and Rheumatology (1.0k citations). Hugues de Lavallade has collaborated with scholars based in United Kingdom, France and United States. Frequent co-authors include Jane F. Apperley, Dragana Milojković, Jamshid S. Khorashad, David Marín, Alistair Reid, John M. Goldman, Marco Bua, Richard Szydlo, Letizia Foroni and Jaspal Kaeda. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Lancet Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.